a year ago
GERN
AnalystsStephen WilleyStephen Willey's Stock Forecasts
AnalystsStephen Willey
Sectors:
Industries:
Analyst Ranking
Top 28%
#1413 out of 5064 analysts
Average Return
+2.31%
Win Rate
44%44 out of 100
Risk vs Reward
Poor
Good
Stephen Willey's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celcuity IncCELC | +300.56% | $12.49 | $50.03 | 2025-07-01 - 2025-10-15 | Strong Buy |
Insmed IncINSM | +226.56% | $21.99 | $71.81 | 2023-08-04 - 2024-08-02 | Strong Buy |
Abcellera Biologics IncABCL | +200.49% | $2.03 | $6.10 | 2025-05-09 - 2025-10-15 | Strong Buy |
Abcellera Biologics IncABCL | +135.98% | $2.59 | $6.10 | 2025-02-28 - 2025-10-15 | Strong Buy |
Igm Biosciences IncIGMS | +130.37% | $4.84 | $11.15 | 2023-11-14 - 2024-11-13 | Strong Buy |
Stephen Willey Analyst Color
Get additional color on Stephen Willey's coverage of popular stocks
Stephen Willey's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Incyte CorpINCY | 7 | Strong Buy | $115.00 | +30.46% | Maintains | 24 days ago |
X4 Pharmaceuticals IncXFOR | 3 | Strong Buy | $9.00 | +214.69% | Maintains | 2 months ago |
Insmed IncINSM | 8 | Strong Buy | $145.00 | -11.34% | Maintains | 2 months ago |
Nkarta IncNKTX | 4 | Strong Buy | $12.00 | +356.27% | Maintains | 2 months ago |
Abcellera Biologics IncABCL | 7 | Strong Buy | $7.00 | +14.75% | Maintains | 2 months ago |
Exelixis IncEXEL | 12 | Hold | $41.00 | +2.42% | Maintains | 3 months ago |
Celcuity IncCELC | 1 | Strong Buy | $30.00 | -40.04% | Reinstates | 4 months ago |
Crescent Biopharma IncCBIO | 2 | Strong Buy | $28.00 | +148.01% | Initiates Coverage On | 4 months ago |
Macrogenics IncMGNX | 4 | Hold | $5.00 | +195.86% | Maintains | 5 months ago |
Bolt Biotherapeutics IncBOLT | 4 | Hold | $20.00 | +233.06% | Maintains | 5 months ago |
Nurix Therapeutics IncNRIX | 5 | Strong Buy | $35.00 | +238.16% | Maintains | 6 months ago |
Vor Biopharma IncVOR | 5 | Strong Buy | $100.00 | +230.91% | Maintains | 7 months ago |
Geron CorpGERN | 3 | Strong Buy | $4.00 | +212.50% | Maintains | 8 months ago |
Igm Biosciences IncIGMS | 4 | Hold | $2.50 | +96.85% | Downgrades | 9 months ago |
Zymeworks IncZYME | 5 | Strong Buy | $28.00 | +50.38% | Maintains | a year ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $47.00 | N/A | Initiates Coverage On | a year ago |
Cue Biopharma IncCUE | 6 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Hillevax IncHLVX | 3 | Hold | $3.00 | N/A | Downgrades | a year ago |
Lite Strategy IncLITS | 9 | Hold | $7.00 | N/A | Maintains | 2 years ago |
Compugen LtdCGEN | 1 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $62.00 | N/A | Maintains | 2 years ago |
Atreca IncBCEL | 3 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 3 years ago |
Omniab IncOABI | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Ars Pharmaceuticals IncSPRY | 1 | Hold | $6.00 | N/A | Downgrades | 4 years ago |
Invivyd IncIVVD | 2 | Hold | $9.00 | N/A | Downgrades | 4 years ago |
Inovio Pharmaceuticals IncINO | 4 | Hold | $288.00 | N/A | Downgrades | 5 years ago |
Seagen IncSGEN | 1 | Hold | $120.00 | N/A | Maintains | 5 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 6 years ago |
Spark Therapeutics IncONCE | 3 | Hold | $114.50 | N/A | Downgrades | 7 years ago |
Alexion Pharmaceuticals IncALXN | 4 | Hold | $136.00 | N/A | Maintains | 7 years ago |
Alnylam Pharmaceuticals IncALNY | 3 | Strong Buy | $123.00 | N/A | Maintains | 7 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Strong Buy | $20.00 | N/A | Maintains | 7 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | $47.00 | N/A | Maintains | 7 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $109.00 | N/A | Maintains | 7 years ago |
Lexicon Pharmaceuticals IncLXRX | 5 | Strong Buy | $23.00 | N/A | Maintains | 7 years ago |
Loxo Oncology IncLOXO | 3 | Strong Buy | $225.00 | N/A | Maintains | 7 years ago |
Innoviva IncINVA | 1 | Hold | $16.00 | N/A | Maintains | 7 years ago |
Akcea Therapeutics IncAKCA | 1 | Strong Buy | $30.00 | N/A | Maintains | 8 years ago |
Array Technologies IncARRY | 1 | Strong Buy | $23.00 | N/A | Maintains | 8 years ago |
Spero Therapeutics IncSPRO | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 8 years ago |
Keryx Biopharmaceuticals IncKERX | 1 | Hold | $5.00 | N/A | Maintains | 8 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.